202 related articles for article (PubMed ID: 32810226)
21. Distribution and molecular evolution of the anti-CRISPR family AcrIF7.
Figueroa W; Cazares A; Cazares D; Wu Y; de la Cruz A; Welch M; Kameyama L; Nobrega FL; Guarneros G
PLoS Biol; 2023 Apr; 21(4):e3002072. PubMed ID: 37083687
[TBL] [Abstract][Full Text] [Related]
22. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
23. Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex.
Guo TW; Bartesaghi A; Yang H; Falconieri V; Rao P; Merk A; Eng ET; Raczkowski AM; Fox T; Earl LA; Patel DJ; Subramaniam S
Cell; 2017 Oct; 171(2):414-426.e12. PubMed ID: 28985564
[TBL] [Abstract][Full Text] [Related]
24. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.
Jia N; Patel DJ
Nat Rev Mol Cell Biol; 2021 Aug; 22(8):563-579. PubMed ID: 34089013
[TBL] [Abstract][Full Text] [Related]
25. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.
Pawluk A; Bondy-Denomy J; Cheung VH; Maxwell KL; Davidson AR
mBio; 2014 Apr; 5(2):e00896. PubMed ID: 24736222
[TBL] [Abstract][Full Text] [Related]
26. A 1.3 Å high-resolution crystal structure of an anti-CRISPR protein, AcrI E2.
Lee SY; Kim GE; Kim YG; Park HH
Biochem Biophys Res Commun; 2020 Dec; 533(4):751-757. PubMed ID: 32988588
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
28. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.
Landsberger M; Gandon S; Meaden S; Rollie C; Chevallereau A; Chabas H; Buckling A; Westra ER; van Houte S
Cell; 2018 Aug; 174(4):908-916.e12. PubMed ID: 30033365
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of dual anti-CRISPR and auto-regulatory functions of AcrIF24.
Kim GE; Lee SY; Birkholz N; Kamata K; Jeong JH; Kim YG; Fineran PC; Park HH
Nucleic Acids Res; 2022 Oct; 50(19):11344-11358. PubMed ID: 36243977
[TBL] [Abstract][Full Text] [Related]
30. The solution structure of an anti-CRISPR protein.
Maxwell KL; Garcia B; Bondy-Denomy J; Bona D; Hidalgo-Reyes Y; Davidson AR
Nat Commun; 2016 Oct; 7():13134. PubMed ID: 27725669
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3.
Wang X; Yao D; Xu JG; Li AR; Xu J; Fu P; Zhou Y; Zhu Y
Nat Struct Mol Biol; 2016 Sep; 23(9):868-70. PubMed ID: 27455460
[TBL] [Abstract][Full Text] [Related]
32. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
[TBL] [Abstract][Full Text] [Related]
33. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.
Mendoza SD; Nieweglowska ES; Govindarajan S; Leon LM; Berry JD; Tiwari A; Chaikeeratisak V; Pogliano J; Agard DA; Bondy-Denomy J
Nature; 2020 Jan; 577(7789):244-248. PubMed ID: 31819262
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for anti-CRISPR repression mediated by bacterial operon proteins Aca1 and Aca2.
Liu Y; Zhang L; Guo M; Chen L; Wu B; Huang H
J Biol Chem; 2021 Dec; 297(6):101357. PubMed ID: 34756887
[TBL] [Abstract][Full Text] [Related]
35. High-resolution crystal structure of the anti-CRISPR protein AcrIC5.
Kang YJ; Park HH
Biochem Biophys Res Commun; 2022 Oct; 625():102-108. PubMed ID: 35952606
[TBL] [Abstract][Full Text] [Related]
36. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage.
Zhang M; Peng R; Peng Q; Liu S; Li Z; Zhang Y; Song H; Yang J; Xing X; Wang P; Qi J; Gao GF
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2215098120. PubMed ID: 37094126
[TBL] [Abstract][Full Text] [Related]
38. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
Mejdani M; Pawluk A; Maxwell KL; Davidson AR
J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic disorder is essential for Cas9 inhibition of anti-CRISPR AcrIIA5.
An SY; Ka D; Kim I; Kim EH; Kim NK; Bae E; Suh JY
Nucleic Acids Res; 2020 Jul; 48(13):7584-7594. PubMed ID: 32544231
[TBL] [Abstract][Full Text] [Related]
40. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
